RARE vs WULF · rev $350.0M vs rev $78.8M
Ultragenyx (RARE) versus Terawulf Inc (WULF) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Terawulf Inc (WULF) is a capital markets company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported WULF revenue for 2026-06-30 was $78.8M. Net income was -$1.37B. WULF currently screens at market cap $2.05B.
RARE currently screens at market cap $2.79B. WULF currently screens at market cap $2.05B.
Not investment advice. Open the RARE and WULF stock pages for the full models.
Not investment advice.